$Novavax(NVAX)$
Aside, clinically, Pfizer and Moderna are muchfaster ahead with their omicron vaccines and Novovax has yet to prove itself to be better than mRNA technology.
On the numbers front, the valuation looks horrible with negative ROE, EBIT per share, ROIC, operative margin trends. Based on PB, a 48 ratio sounds insane.
I am not certain about the MOAT of this company and hence will not attempt any sensible valuation.
My advise will be to STAY AWAY.
What do you think? Let me know if you have some valuable insights for Novovax.
Aside, some of you will be facing situations like this right now. Oh ya did I mention there's a new virus from China called the Henipavirus spreading now? [Facepalm]
@TigerStars@CaptainTiger@MillionaireTiger
Comments